awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35034708-0BA363DF-B2F3-4C24-82EF-601F99A1C76E
Q35034708-0BA363DF-B2F3-4C24-82EF-601F99A1C76E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35034708-0BA363DF-B2F3-4C24-82EF-601F99A1C76E
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
P2860
Q35034708-0BA363DF-B2F3-4C24-82EF-601F99A1C76E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35034708-0BA363DF-B2F3-4C24-82EF-601F99A1C76E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4e7b44841254216e4e485262d41fad3fce5c97e
P2860
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.